The Interim Results of a Multicenter study of Safety and Efficacy of Vemurafenib and Cytarbine plus Cladribine Therapy in high-risk Pediatric Langerhans cell Histiocytosis with Braf V600E Mutation

被引：0
|
作者：
Evseev, Dmitry [1 ]
Osipova, Daria [1 ]
Kalinina, Irina [1 ]
Raykina, Elena [1 ]
Popov, Alexander [1 ]
Kotskaya, Natalia [1 ]
Chernyak, Ekaterina [1 ]
Burtsev, Evgeny [2 ]
Bronin, Gleb [2 ]
Tayshikhina, Irina [2 ]
Purbueva, Bazarma [3 ]
Fink, Olesya [3 ]
Pristanskova, Ekaterina [3 ]
Novitchkova, Galina [1 ]
Maschan, Alexey [1 ]
Maschan, Michael [1 ]
机构：
[1] Dmitry Rogachev Natl Res Ctr, Moscow, Russia
[2] Morozovskaya Children City Clin Hosp, Moscow, Russia
[3] Russian Childrens Clin Hosp, Moscow, Russia
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [21] Frequent BRAF(V600E) mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis
    Wei, Rui
    Wang, Zhongqing
    Li, Xiaolin
    Shu, Yigang
    Fu, Bin
    BIOMEDICAL REPORTS, 2013, 1 (03) : 365 - 368
  • [22] Langerhans cell histiocytosis of bone with BRAF V600E mutation: a case report and the review of published work
    Terzi, N. Kaya
    Yilmaz, I.
    VIRCHOWS ARCHIV, 2019, 475 : S414 - S414
  • [23] Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing
    Feng, Shunqiao
    Han, Lin
    Yue, Mei
    Zhong, Dixiao
    Cao, Jing
    Guo, Yibing
    Sun, Yanling
    Zhang, Hao
    Cao, Zhenhua
    Cui, Xiaodai
    Liu, Rong
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [24] Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing
    Shunqiao Feng
    Lin Han
    Mei Yue
    Dixiao Zhong
    Jing Cao
    Yibing Guo
    Yanling Sun
    Hao Zhang
    Zhenhua Cao
    Xiaodai Cui
    Rong Liu
    Orphanet Journal of Rare Diseases, 16
  • [25] A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
    Thu Dang Anh Phan
    Bao Gia Phung
    Tu Thanh Duong
    Vu Anh Hoang
    Dat Quoc Ngo
    Nguyen Dinh The Trinh
    Tung Thanh Tran
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2021, 55 (02) : 112 - 117
  • [26] CASE REPORT: RESPONSE TO BRAF V600E INHIBITOR VEMURAFENIB AND ADOPTIVE IMMUNOTHERAPY IN A PATIENT WITH MULTISYSTEMIC AND REFRACTORY LANGERHANS CELL HISTIOCYTOSIS
    Sun, F.
    Sun, X.
    Zhen, Z.
    Zhu, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 152 - 152
  • [27] Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?
    Moschovi, Maria
    Adamaki, Maria
    Vlahopoulos, Spiros
    Rodriguez-Galindo, Carlos
    PEDIATRIC BLOOD & CANCER, 2015, 62 (01) : 173 - 174
  • [28] HLX208, a novel BRAF V600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harbouring BRAF V600E mutation
    Cao, X-X.
    Wu, Y.
    Liu, P.
    Ding, T.
    Ye, H.
    Cai, Z.
    Zhang, Y.
    Ma, J.
    Xu, Y.
    Fu, G.
    Hu, C.
    Hou, X.
    Wang, Q.
    Zhu, J.
    Li, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1599 - S1599
  • [29] Localized Langerhans cell, histiocytosis of the thymus with BRAF V600E mutation: a case report with immunohistochemical and genetic analyses
    Oishi, Naoki
    Kondo, Tetsuo
    Mochizuki, Kunio
    Inoue, Tomohiro
    Kasai, Kazunari
    Nakazawa, Tadao
    Mitsumori, Toru
    Katoh, Ryohei
    HUMAN PATHOLOGY, 2014, 45 (06) : 1302 - 1305
  • [30] The Effect of BRAF V600E Mutation in the CD207+Cell of Langerhans Cell Histiocytosis on the Clinical Presentation and the Transcriptome
    Peters, Tricia
    Lim, Phaik H.
    Hicks, M. John
    McClain, Kenneth L.
    Allen, Carl E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A220 - A220
12345